+
Site Tour

Search

Showing 31 - 40 of 523 results.

  • Overview

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding PDA closure If PDA is left untreated, the mortality rate is 20% by age 20 years,
  • Clinical Data

    Tendyne™ TMVR improves your patients’ function and quality of life, with clinically significant improvement in a 6-minute walk test2 and Kansas City Cardiomyopathy Questionnaire (KCCQ) scores.1 The
  • Overview

    LEARN MORE: AMPLATZER™ DUCT OCCLUDERS   AMPLATZER™ PICCOLO™ OCCLUDER WATCH ON-DEMAND:​ PDA Symposium 2024 If PDA is left untreated, the mortality rate is 20% by age 20 years,
  • Overview

    TRI-SCORE RISK SCORE MODEL FOR ISOLATED TRICUSPID VALVE SURGERY Secondary TR arising from RV remodelling can be classified in three progressive stages26 Initial Right Ventricular (RV) dilatation
  • Diagnosis

    Patients with a moderate left-to-right shunt may remain asymptomatic for years. However, historical series have shown that chronic volume overload may ultimately lead to severe complications: Co
  • Overview

    LEARN MORE:​ DIAGNOSIS TREATMENT © Abbott 2025. All rights reserved. 9-EH-5-15859-01 02-2025
  • Overview

    LEARN MORE:​ DIAGNOSIS TREATMENT
  • Overview

    TREATMENT RANGE 4 MM TO 40 MM No other ASD closure device on the market today can match ASO’s wide range of device sizes.
  • Overview

    SWITCH TO THE REFERRAL VIEW    For more information specific to neonatology regarding PDA closure LEARN MORE: PDA Symposium 2024
  • Overview

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding PFO closure  LEARN MORE: Talisman vs. Gore   Talisman vs. Occlutech THE PFO OCCLUDER

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline